Stock INNO INNOCAN PHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Delayed Canadian Securities Exchange
Other stock markets
 11:42:47 2024-04-25 am EDT 		5-day change 1st Jan Change
0.275 CAD 0.00% Intraday chart for InnoCan Pharma Corporation 0.00% -11.29%
Apr. 01 InnoCan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Innocan Pharma Corporation Announces the Signing of an Agreement with the Hebrew University CI

Business Summary

Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Online Sales
99.2 %
- - 18 99.2 % -
Other
0.8 %
- - 0 0.8 % -

Sales per region

CAD in Million2022Weight2023Weight Delta
United States
99.2 %
3 94.5 % 18 99.2 % +481.12%
Rest of the World
0.8 %
0 2.3 % 0 0.8 % +91.53%

Managers

Managers TitleAgeSince
Nir Avram FOU
 Founder 71 -
Iris Bincovich FOU
 Founder - 18-05-30
Nelson Halpern DFI
 Director of Finance/CFO - 19-02-19
Roni Kamhi COO
 Chief Operating Officer - 22-08-10
Eyal Flom BRD
 Director/Board Member 59 19-09-24

Members of the board

Members of the board TitleAgeSince
Peter Bloch BRD
 Director/Board Member 64 20-01-21
Ron Abraham Mayron CHM
 Chairman 59 14-05-31
Iris Bincovich FOU
 Founder - 18-05-30
Eyal Flom BRD
 Director/Board Member 59 19-09-24
Ralph Bossino BRD
 Director/Board Member - 19-09-29
Joshua Lintern BRD
 Director/Board Member 37 19-09-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 275,954,735 237,568,576 ( 86.09 %) 0 86.09 %

Shareholders

NameEquities%Valuation
Solsken Ltd.
18.55 %
49,726,311 18.55 % 11 M $
Ron Abraham Mayron
2.383 %
6,387,777 2.383 % 1 M $
Iris Bincovich
1.843 %
4,939,122 1.843 % 1 M $
Eyal Flom
0.8863 %
2,375,277 0.8863 % 534 437 $
PP-Asset Management GmbH
0.1970 %
528,000 0.1970 % 118 800 $
Nelson Halpern
0.1345 %
360,333 0.1345 % 81 075 $
Ralph Bossino
0.0920 %
246,666 0.0920 % 55 500 $
Roni Kamhi
0.0829 %
222,222 0.0829 % 50 000 $
Joshua Lintern
0.0598 %
160,333 0.0598 % 36 075 $
Peter Bloch
0.0269 %
72,222 0.0269 % 16 250 $

Company contact information

InnoCan Pharma Corp.

926-5th Avenue SW Suite 1015

T2P 0N7, Calgary

+403-777-1519

http://www.innocanpharma.com
address InnoCan Pharma Corporation(INNO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
INNOCAN PHARMA CORPORATION Stock InnoCan Pharma Corporation
-11.29% 56.25M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.39% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.24% 322B
ABBVIE INC. Stock AbbVie Inc.
+7.67% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.34% 149B
AMGEN INC. Stock Amgen Inc.
-6.87% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INNO Stock
  4. Company InnoCan Pharma Corporation